AUG 10, 2026 · PHASE 2 TRIAL
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ClinicalTrials.gov
This is a Phase 2 proof-of-concept study registration with no results reported; the trial is actively recruiting and designed to explore HER3-DXd monotherapy across multiple solid tumor types.
Reported
Estimated enrollment740
PhasePHASE 2
Primary outcome (non-prostate coh…Number of Participants With Objective Respo…